Pharmaceutical Technology, Apr 1, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Apr 1, 2011
Special Feature
Audio: Excipient Functionality and Continuous Manufacturing
Listen to roundtables from the 2011 ExcipientFest/IPEC conference, addressing developing issues in excipient functionality and continuous manufacturing.
Featured Content
Exploring Excipient Functionality
By Patricia Van Arnum
This technical forum is part of a special issue on Solid Dosage and Excipients.
Innovations in Tablet Coating
Representatives from Pfizer R&D, DEM Solutions, Colorcon, and ARmark Authentication Technologies provide insight into recent tablet-coating technologies.
Oral-Absorption-Enhancing Drug-Delivery Technology
By Edwin G. Walsh , John S. Fox , Thomas W. Leonard
The authors examine an oral-absorption-enhancement technology based on surface-active materials to increase apical membrane fluidity in vitro.
Correlating Die-Filling Performance with Powder Properties
By Tim Freeman
The author explains how to gain an understanding of the relationships between powder characteristics and process performance to match filling-machine geometry to the demands of specific formulations.
Risk Assessment for Excipients for Enhanced Patient Safety
By Dale Carter
The author describes key considertions for a complete risk-assessment model and provides insight into a pending IPEC guideline in this area.
Total Excipient Control: A Pathway to Increased Patient Safety
By David R. Schoneker
The author focuses on how industry can build a system for Total Excipient Control.
Exploring Nanotechnology in Drug Delivery
By Patricia Van Arnum
Nanotechnology often is associated with parenteral drug delivery, particularly for anticancer therapies, but it also has applications in oral drug delivery

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here